[1]
Geving Andersen, K. et al. 2012. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncologica. 51, 8 (Nov. 2012), 1036–1044. DOI:https://doi.org/10.3109/0284186X.2012.692884.